APA
SAGE

American Portfolios Advisors’s Sage Therapeutics SAGE Stock Holding History

American Portfolios Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,384
Closed -$39.7K – 2892
2020
Q1 		$39.7K Buy
+1,384
New +$80.1K ﹤0.01% 1260

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

American Portfolios Advisors's SAGE Position: Q2 2020 in Review

American Portfolios Advisors sold out of Sage Therapeutics (SAGE) in Q2 2020, closing a stake of 1,384 shares — an estimated $39.7K sold.

American Portfolios Advisors first reported a position in SAGE in Q1 2020 and held it in 1 quarter. The position peaked at $39.7K in Q1 2020. 216 funds tracked by Wall St. Rank hold SAGE as of Q2 2020.

  • American Portfolios Advisors reported no remaining Sage Therapeutics position as of Q2 2020 after selling out during the quarter.
  • American Portfolios Advisors sold 1,384 Sage Therapeutics shares in Q2 2020, an estimated $39.7K.
  • American Portfolios Advisors first reported a position in Sage Therapeutics in Q1 2020 and held it in 1 quarter.
  • American Portfolios Advisors's Sage Therapeutics position peaked at $39.7K in Q1 2020.
  • 216 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2020.

Based on American Portfolios Advisors's 13F filing for Q2 2020, filed 24 Mar 2023.